Intracellular deoxyribonucleotide pool imbalance and DNA damage in cells treated with hydroxyurea, an inhibitor of ribonucleotide reductase

Mutagenesis

Volumn 28, Issue 6, 2013, Pages 653-660

  Golkar, Siv Osterman ^a   Czene, Stefan ^b   Gokarakonda, Amulya ^a   Haghdoost, Siamak ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYRIBONUCLEOTIDE; DNA; HYDROXYUREA; RIBONUCLEOTIDE REDUCTASE;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG EFFECT; ENZYME INHIBITION; GENOTOXICITY; HEAT TREATMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LYMPHOMA CELL; MICRONUCLEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANIMALS; CELL LINE, TUMOR; COMET ASSAY; DEOXYRIBONUCLEOTIDES; DNA DAMAGE; HYDROXYUREA; MICE; MICRONUCLEUS TESTS; MUTAGENS; RIBONUCLEOTIDE REDUCTASES;

EID: 84888589861     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/get044     Document Type: Article

References (22)

1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite (2011) Guideline. Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. S2(R1). Current Step 4 version. http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Safety/ S2-R1/Step4/S2R1-Step4.pdf (accessed November 9, 2011).
2. Clive, D., Johnson, K. O., Spector, J. F., Batson, A. G. and Brown, M. M. (1979) Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. Mutat. Res., 59, 61-108.
3. Kirsch-Volders, M., Plas, G., Elhajouji, A., Lukamowicz, M., Gonzalez, L., Vande Loock, K. and Decordier, I. (2011) The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch. Toxicol., 85, 873-899.
4. Kirkland, D., Aardema, M., Henderson, L. and Muller, L. (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res., 584, 1-256.
5. Kirkland, D. J., Aardema, M., Banduhn, N., Carmichael, P., Fautz, R., Meunier, J. R. and Pfuhler, S. (2007) In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results. Mutagenesis, 22, 161-175.
6. Kunz, B. A. (1988) Mutagenesis and deoxyribonucleotide pool imbalance. Mutat. Res., 200, 133-147.
7. Kunz, B. A., Kohalmi, S. E., Kunkel, T. A., Mathews, C. K., McIntosh, E. M. and Reidy, J. A. (1994) International Commission for Protection Against Environmental Mutagens and Carcinogens. Deoxyribonucleoside triphosphate levels: A critical factor in the maintenance of genetic stability. Mutat. Res., 318, 1-64.
8. Grob, M. K., O'Brien, K., Chu, J. J. and Chen, D. D. (2003) Optimization of cellular nucleotide extraction and sample preparation for nucleotide pool analyses using capillary electrophoresis. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 788, 103-111.
9. Gebelein, M., Merdes, G. and Berger, M. R. (1992) Nucleotide preparation from cells and determination of nucleotides by ion-pair high-performance liquid chromatography. J. Chromatogr., 577, 146-150.
10. Au, J. L., Su, M. H. and Wientjes, M. G. (1989) Extraction of intracellular nucleosides and nucleotides with acetonitrile. Clin. Chem., 35, 48-51.
11. Traut, T. W. (1994) Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem., 140, 1-22.
12. Booth, J. A., Ockey, C. H. and Saffhill, R. (1987) The sizes of cellular deoxynucleoside 5'-triphosphate pools in relation to sensitivity to electron irradiation using sensitive and resistant cell lines. Carcinogenesis, 8, 409-414.
13. Roy, B., Beuneu, C., Roux, P., Buc, H., Lemaire, G. and Lepoivre, M. (1999) Simultaneous determination of pyrimidine or purine deoxyribonucleoside triphosphates using a polymerase assay. Anal. Biochem., 269, 403-409.
14. Song, S., Wheeler, L. J. and Mathews, C. K. (2003) Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J. Biol. Chem., 278, 43893-43896.
15. Shewach, D. S. (1992) Quantitation of deoxyribonucleoside 5'-triphosphates by a sequential boronate and anion-exchange high-pressure liquid chromatographic procedure. Anal. Biochem., 206, 178-182.
16. Tyrsted, G. (1982) Effect of hydroxyurea and 5-fluorodeoxyuridine on deoxyribonucleoside triphosphate pools early in phytohemagglutinin-stimulated human lymphocytes. Biochem. Pharmacol., 31, 3107-3113.
17. Fox, R. M. (1985) Changes in deoxynucleoside triphosphate pools induced by inhibitors and modulators of ribonucleotide reductase. Pharmacol. Ther., 30, 31-42.
18. Yarbro, J. W. (1992) Mechanism of action of hydroxyurea. Semin. Oncol., 19, 1-10.
19. Roy, B., Guittet, O., Beuneu, C., Lemaire, G. and Lepoivre, M. (2004) Depletion of deoxyribonucleoside triphosphate pools in tumor cells by nitric oxide. Free Radic. Biol. Med., 36, 507-516.
20. Walker, I. G., Yatscoff, R. W. and Sridhar, R. (1977) Hydroxyurea: induction of breaks in template strands of replicating DNA. Biochem. Biophys. Res. Commun., 77, 403-408.
21. Wangenheim, J. and Bolcsfoldi, G. (1988) Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds. Mutagenesis, 3, 193-205.
22. Asgard, R., Haghdoost, S., Osterman-Golkar, S., Hellman, B. and Czene, S. (2013) Evidence for different mechanisms of action behind the mutagenic effects of 4-NOPD and OPD: The role of DNA damage, oxidative stress and an imbalanced nucleotide pool. Mutagenesis. 2013 August 13 [Epub ahead of print], doi:10.1093/mutage/get041.